BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbour T, Johnson S, Cohney S, Hughes P. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012;27:2673-2685. [PMID: 22802583 DOI: 10.1093/ndt/gfs279] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 12.1] [Reference Citation Analysis]
Number Citing Articles
1 Reig Mezquida JP, Jover AS, Ansótegui Barrera E, Escrivá Peiró J, Pastor Colom MD, Pastor Guillem J. Microangiopatía trombótica asociada a tacrolimus en trasplante pulmonar. Archivos de Bronconeumología 2015;51:e23-4. [DOI: 10.1016/j.arbres.2014.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Alavi P, Rathod AM, Jahroudi N. Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor. J Clin Med 2021;10:4190. [PMID: 34575297 DOI: 10.3390/jcm10184190] [Reference Citation Analysis]
3 Yang Y, Yu B, Chen Y. Blood disorders typically associated with renal transplantation. Front Cell Dev Biol. 2015;3:18. [PMID: 25853131 DOI: 10.3389/fcell.2015.00018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
4 Cheung V, Trachtman H. Hemolytic uremic syndrome: toxins, vessels, and inflammation. Front Med (Lausanne) 2014;1:42. [PMID: 25593915 DOI: 10.3389/fmed.2014.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
5 Keir LS. Shiga Toxin Associated Hemolytic Uremic Syndrome. Hematology/Oncology Clinics of North America 2015;29:525-39. [DOI: 10.1016/j.hoc.2015.01.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
6 Lukasz A, Beneke J, Thamm K, Kielstein JT, Menne J, Mikesch JH, Schmidt BM, Haller H, Kümpers P, David S, Schiffer M. Involvement of Angiopoietin-2 and Tie2 Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4. Mediators Inflamm 2015;2015:670248. [PMID: 26858516 DOI: 10.1155/2015/670248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Doulgere J, Otto B, Nassour M, Wolters-Eisfeld G, Rohde H, Magnus T, Wagener C, Streichert T. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study. BMJ Open 2015;5:e005659. [PMID: 25757942 DOI: 10.1136/bmjopen-2014-005659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
8 Buder K, Latal B, Nef S, Neuhaus TJ, Laube GF, Spartà G. Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome. Pediatr Nephrol 2015;30:503-13. [PMID: 25234636 DOI: 10.1007/s00467-014-2950-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
9 Auricchio F, Scavone C, Cimmaruta D, Di Mauro G, Capuano A, Sportiello L, Rafaniello C. Drugs approved for the treatment of multiple sclerosis: review of their safety profile. Expert Opin Drug Saf 2017;16:1359-71. [PMID: 28976217 DOI: 10.1080/14740338.2017.1388371] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
10 Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56-76 [PMID: 24255888 DOI: 10.5527/wjn.v2.i3.56] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
11 Yu XJ, Yu F, Song D, Wang SX, Song Y, Liu G, Zhao MH. Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China. ScientificWorldJournal 2014;2014:680502. [PMID: 25184151 DOI: 10.1155/2014/680502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
12 Barbour TD, Crosthwaite A, Chow K, Finlay MJ, Better N, Hughes PD, Cohney SJ. Antiphospholipid syndrome in renal transplantation. Nephrology (Carlton). 2014;19:177-185. [PMID: 24548061 DOI: 10.1111/nep.12217] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
13 Crnogorac M, Horvatic I, Kacinari P, Ljubanovic DG, Galesic K. Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome. J Nephrol 2018;31:257-62. [PMID: 29027625 DOI: 10.1007/s40620-017-0445-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
14 De La Flor JC, Alonso M, Sandoval E, Marschall A, Rodeles M. Monoclonal Gammopathy of Renal Significance with Deposits of Peculiar Morphology and Injuries of Secondary Thrombotic Microangiopathy: A Case Report and Review of the Literature. Case Rep Nephrol 2020;2020:6679857. [PMID: 33376611 DOI: 10.1155/2020/6679857] [Reference Citation Analysis]
15 Namal Rathnayaka RMMK, Nishanthi Ranathunga PEA, Kularatne SAM. Thrombotic Microangiopathy Following Hypnale zara (Hump-Nosed Pit Viper) Envenoming: The First Known Case Report from Sri Lanka. Wilderness Environ Med 2020;31:71-7. [PMID: 31870797 DOI: 10.1016/j.wem.2019.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Rees L. Atypical HUS: time to take stock of current guidelines and outcome measures? Pediatr Nephrol 2013;28:675-7. [PMID: 23389238 DOI: 10.1007/s00467-013-2423-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rataj D, Werwitzke S, Haarmeijer B, Winkler M, Ramackers W, Petersen B, Niemann H, Wünsch A, Bähr A, Klymiuk N, Wolf E, Abicht J, Ayares D, Tiede A. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation. Xenotransplantation 2016;23:117-27. [DOI: 10.1111/xen.12218] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
18 Walker JJA, Holm LP, Sarmiento ÓG, Caianiello R, Cortellini S, Walker DJ. Clinicopathological features of cutaneous and renal glomerular vasculopathy in 178 dogs. Vet Rec 2021;189:e72. [PMID: 33829498 DOI: 10.1002/vetr.72] [Reference Citation Analysis]
19 Keir LS, Saleem MA. Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol 2014;29:1895-902. [PMID: 23843163 DOI: 10.1007/s00467-013-2561-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
20 Khurshid Q, Mahmoud A, Shahid M, Mohamed A, Shahbaz A. Atypical Hemolytic Uremic Syndrome Associated With Clostridium Difficile Infection. Cureus 2020;12:e9005. [PMID: 32775085 DOI: 10.7759/cureus.9005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Wijnsma KL, Veissi ST, de Wijs S, van der Velden T, Volokhina EB, Wagener FADTG, van de Kar NCAJ, van den Heuvel LP. Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome. Front Immunol 2020;11:547406. [PMID: 33414780 DOI: 10.3389/fimmu.2020.547406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lu S, Liu S, Wietelmann A, Kojonazarov B, Atzberger A, Tang C, Schermuly RT, Gröne HJ, Offermanns S. Developmental vascular remodeling defects and postnatal kidney failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4). PLoS One 2017;12:e0183166. [PMID: 28806758 DOI: 10.1371/journal.pone.0183166] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
23 Kuroki Y, Mitsuiki K, Nakagawa K, Tsuruya K, Katafuchi R, Hirakata H, Nakano T. Late renal recovery after treatment over 1 year post-onset in an atypical hemolytic uremic syndrome: a case report. BMC Nephrol 2020;21:236. [PMID: 32571244 DOI: 10.1186/s12882-020-01897-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Vosoughi R, Marriott JJ. Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases. Mult Scler Relat Disord. 2014;3:321-325. [PMID: 25876469 DOI: 10.1016/j.msard.2013.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
25 Holmes S, Podger L, Bottomley C, Rzepa E, Bailey KMA, Chandler F. Survival after acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) - cognitive functioning and health-related quality of life impact: a descriptive cross-sectional survey of adults living with iTTP in the United Kingdom. Hematology 2021;26:465-72. [PMID: 34238132 DOI: 10.1080/16078454.2021.1945236] [Reference Citation Analysis]
26 Ekart R, Grobelšek VK, Dai K, Cernelč P, Hojs R. Rare manifestation of the thrombotic microangiopathy in a patient with sarcoidosis, common variable immunodeficiency and large B-cell non-hodgkin lymphoma: case report. Transfus Apher Sci 2013;48:345-7. [PMID: 23619325 DOI: 10.1016/j.transci.2013.04.014] [Reference Citation Analysis]
27 Aziz F, Clark D, Garg N, Mandelbrot D, Djamali A. Hypertension guidelines: How do they apply to kidney transplant recipients. Transplantation Reviews 2018;32:225-33. [DOI: 10.1016/j.trre.2018.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
28 Guo HY, Sun J, Su Y, Zhang Q, Hua R, Xia X, Fang D. Thrombotic microangiopathy led to acute kidney injury in an infant with hemophagocytic lymphohistiocytosis: A case report. Exp Ther Med 2021;21:396. [PMID: 33680118 DOI: 10.3892/etm.2021.9827] [Reference Citation Analysis]
29 Filho JCCL, Ogawa MY, de Souza Andrade TH, de Andrade Cordeiro Gadelha S, Fernandes PFCBC, Queiroz AL, Daher EF. Spectrum of acute kidney injury associated with cocaine use: report of three cases. BMC Nephrol 2019;20:99. [PMID: 30894132 DOI: 10.1186/s12882-019-1279-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Bae MN, Kwak DH, Park SJ, Choi BS, Park CW, Choi YJ, Lee JW, Yang CW, Kim YS, Chung BH. Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis. BMC Nephrol 2016;17:4. [PMID: 26739581 DOI: 10.1186/s12882-015-0217-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
31 Nishi K, Sato M, Ogura M, Okutsu M, Ishikura K, Kamei K. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy. BMC Nephrol 2020;21:323. [PMID: 32746791 DOI: 10.1186/s12882-020-01985-5] [Reference Citation Analysis]
32 Jepson RE, Cardwell JM, Cortellini S, Holm L, Stevens K, Walker D. Cutaneous and Renal Glomerular Vasculopathy: What Do We Know so Far? Vet Clin North Am Small Anim Pract 2019;49:745-62. [PMID: 30961997 DOI: 10.1016/j.cvsm.2019.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Tseng MH, Fan WL, Liu H, Yang CY, Ding JJ, Lee HJ, Huang SM, Lin SH, Huang JL. Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis. Front Med (Lausanne) 2020;7:621609. [PMID: 33614676 DOI: 10.3389/fmed.2020.621609] [Reference Citation Analysis]
34 Negrini S, Durrbach A, Becquemont L. Sirolimus-related systemic thrombotic microangiopathy after renal transplantation. Therapie 2014;69:175-7. [PMID: 24926637 DOI: 10.2515/therapie/2014020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Larkin CM, Santos-Martinez MJ, Ryan T, Radomski MW. Sepsis-associated thrombocytopenia. Thromb Res. 2016;141:11-16. [PMID: 26953822 DOI: 10.1016/j.thromres.2016.02.022] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
36 Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM. Síndrome hemolítico urémico atípico. Medicina Clínica 2015;145:438-45. [DOI: 10.1016/j.medcli.2014.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Pisco V, Beck S, Walker JJ, Lopes B, Ives E, Holm LP, Walker DJ. Cerebral Microangiopathy in Two Dogs with Cutaneous and Renal Glomerular Vasculopathy. J Comp Pathol 2021;184:95-100. [PMID: 33894885 DOI: 10.1016/j.jcpa.2021.03.001] [Reference Citation Analysis]
38 Nadasdy T. Thrombotic microangiopathy in renal allografts: the diagnostic challenge. Curr Opin Organ Transplant. 2014;19:283-292. [PMID: 24811438 DOI: 10.1097/mot.0000000000000074] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
39 Gonzalez Suarez ML, Thongprayoon C, Mao MA, Leeaphorn N, Bathini T, Cheungpasitporn W. Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis. J Clin Med 2019;8:E919. [PMID: 31252541 DOI: 10.3390/jcm8070919] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
40 Beneke J, Sartison A, Kielstein JT, Haller H, Nitschke M, Kunzendorf U, Loos S, Kemper MJ, Stahl RA, Menne J; German 2011 STEC-HUS outbreak study group. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome. Transfus Med Rev 2017;31:51-5. [PMID: 27468945 DOI: 10.1016/j.tmrv.2016.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
41 Okazaki M, Yaomura T, Tsuboi T, Mizuno S, Nakamura T, Hasegawa T, Katayama M, Nakamura H, Iida H, Saito T, Maruyama S, Matsuo S. A case of acute renal failure of multiple myeloma due to monoclonal type I cryoglobulinemia with thrombotic microangiopathy. CEN Case Rep 2015;4:174-9. [PMID: 28509095 DOI: 10.1007/s13730-014-0162-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
42 Sakthirajan R, Dhanapriya J, Dineshkumar T, Gopalakrishnan N, Murugan S, Balasubramaniyan T. Thrombotic microangiopathy: An unusual cause of renal failure in rheumatoid arthritis. Indian J Nephrol 2017;27:81-3. [PMID: 28182045 DOI: 10.4103/0971-4065.179207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Qaqish I, Schlam IM, Chakkera HA, Fonseca R, Adamski J. Carfilzomib: A cause of drug associated thrombotic microangiopathy. Transfusion and Apheresis Science 2016;54:401-4. [DOI: 10.1016/j.transci.2016.03.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
44 Licht C, Ardissino G, Ariceta G, Cohen D, Cole JA, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Schaefer F, Vande Walle J, Frémeaux-Bacchi V. The global aHUS registry: methodology and initial patient characteristics. BMC Nephrol 2015;16:207. [PMID: 26654630 DOI: 10.1186/s12882-015-0195-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
45 Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand: Thrombotic microangiopathy in Aust/NZ. Nephrology 2018;23:507-17. [DOI: 10.1111/nep.13234] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
46 Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand: Thrombotic microangiopathy in Australia/New Zealand. Intern Med J 2018;48:624-36. [DOI: 10.1111/imj.13804] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
47 Buob D, Decambron M, Gnemmi V, Frimat M, Hoffmann M, Azar R, Gheerbrant J, Guincestre T, Noël C, Copin M, Glowacki F. Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney. Kidney International 2016;90:1321-31. [DOI: 10.1016/j.kint.2016.07.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
48 Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. BMC Infect Dis 2016;16:285. [PMID: 27297224 DOI: 10.1186/s12879-016-1627-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
49 Sciascia S, Baldovino S, Schreiber K, Solfietti L, Roccatello D. Antiphospholipid Syndrome and the Kidney. Semin Nephrol 2015;35:478-86. [PMID: 26573550 DOI: 10.1016/j.semnephrol.2015.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
50 Bogaerts B, Nouws S, Verhaegen B, Denayer S, Van Braekel J, Winand R, Fu Q, Crombé F, Piérard D, Marchal K, Roosens NHC, De Keersmaecker SCJ, Vanneste K. Validation strategy of a bioinformatics whole genome sequencing workflow for Shiga toxin-producing Escherichia coli using a reference collection extensively characterized with conventional methods. Microb Genom 2021;7. [PMID: 33656437 DOI: 10.1099/mgen.0.000531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
51 Ravindran A, Go RS, Fervenza FC, Sethi S. Thrombotic microangiopathy associated with monoclonal gammopathy. Kidney Int 2017;91:691-8. [PMID: 27998645 DOI: 10.1016/j.kint.2016.09.045] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
52 Cicora F, Paz M, Mos F, Roberti J. Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy. Case Rep Med. 2013;2013:260254. [PMID: 24198835 DOI: 10.1155/2013/260254] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
53 Sethi A, Moses R. Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced? Cureus 2021;13:e13260. [PMID: 33717763 DOI: 10.7759/cureus.13260] [Reference Citation Analysis]
54 Ding J, Qu Z, Yu F. A rare case of malignant hypertension with splenic rupture and thrombotic microangiopathy: A case report. Medicine (Baltimore) 2020;99:e20581. [PMID: 32664062 DOI: 10.1097/MD.0000000000020581] [Reference Citation Analysis]
55 Paul F, Murphy O, Pardo S, Levy M. Investigational drugs in development to prevent neuromyelitis optica relapses. Expert Opinion on Investigational Drugs 2018;27:265-71. [DOI: 10.1080/13543784.2018.1443077] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
56 Mathew RO, Nayer A, Asif A. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. J Am Soc Hypertens 2016;10:352-9. [PMID: 26778772 DOI: 10.1016/j.jash.2015.12.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
57 Caeiro Alves F, Aguiar R, Pessegueiro P, Pires C. Thrombotic microangiopathy associated with Mycoplasma pneumoniae infection. BMJ Case Rep 2018;2018:bcr-2017-222582. [PMID: 29550758 DOI: 10.1136/bcr-2017-222582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 de Andrade LGM, Contti MM, Nga HS, Bravin AM, Takase HM, Viero RM, da Silva TN, Chagas KN, Palma LMP. Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice. PLoS One 2017;12:e0188155. [PMID: 29136640 DOI: 10.1371/journal.pone.0188155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
59 Yenerel MN. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management. Turk J Haematol 2014;31:216-25. [PMID: 25319590 DOI: 10.4274/tjh.2013.0374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Umeda M, Fukui S, Sumiyoshi R, Kitamura M, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A. Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection. Intern Med 2019;58:441-5. [PMID: 30146597 DOI: 10.2169/internalmedicine.1441-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
61 Vazquez Martul E. [Thrombotic microangiopathy/haemolytic uraemic syndrome. Histopathology update]. Rev Esp Patol 2018;51:170-7. [PMID: 30012310 DOI: 10.1016/j.patol.2017.10.007] [Reference Citation Analysis]
62 Barbour TD, Pickering MC, Terence Cook H. Dense deposit disease and C3 glomerulopathy. Semin Nephrol 2013;33:493-507. [PMID: 24161036 DOI: 10.1016/j.semnephrol.2013.08.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
63 Barbour TD, Pickering MC, Cook HT. Recent insights into C3 glomerulopathy. Nephrol Dial Transplant. 2013;28:1685-1693. [PMID: 23479095 DOI: 10.1093/ndt/gfs430] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
64 Giustozzi M, Ehrlinder H, Bongiovanni D, Borovac JA, Guerreiro RA, Gąsecka A, Papakonstantinou PE, Parker WAE. Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment. Blood Rev 2021;:100864. [PMID: 34217531 DOI: 10.1016/j.blre.2021.100864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Sakamaki Y, Konishi K, Hayashi K, Hashiguchi A, Hayashi M, Kubota E, Saruta T, Itoh H. Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation. BMC Nephrol 2013;14:260. [PMID: 24279773 DOI: 10.1186/1471-2369-14-260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kang E, Yoo SH, Oh D, Joo KW, Kim YS, Yoon SS, Kim I, Park S, Lee H, Koh Y. Clinical dissection of thrombotic microangiopathy. Ann Hematol 2017;96:1715-26. [PMID: 28752391 DOI: 10.1007/s00277-017-3063-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
67 Sarno L, Stefanovic V, Maruotti GM, Zullo F, Martinelli P. Thrombotic microangiopathies during pregnancy: The obstetrical and neonatal perspective. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019;237:7-12. [DOI: 10.1016/j.ejogrb.2019.03.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
68 Joseph C, Gattineni J. Complement disorders and hemolytic uremic syndrome. Curr Opin Pediatr 2013;25:209-15. [PMID: 23399570 DOI: 10.1097/MOP.0b013e32835df48a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
69 Pan FF, Hidayati L, Hughes P, Murugasu A, Masterson R. Case report: thrombotic microangiopathy post-intravenous immunoglobulin in the context of BK nephropathy and renal transplantation. Transplant Proc 2014;46:278-80. [PMID: 24507067 DOI: 10.1016/j.transproceed.2013.10.038] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
70 Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M. Eculizumab in secondary atypical haemolytic uraemic syndrome. Nephrol Dial Transplant 2017;32:466-74. [PMID: 28339660 DOI: 10.1093/ndt/gfw453] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 13.4] [Reference Citation Analysis]
71 Kausman JY, Powell HR. Paediatric nephrology: the last 50 years. J Paediatr Child Health 2015;51:94-7. [PMID: 25537024 DOI: 10.1111/jpc.12812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Grisaru S. Management of hemolytic-uremic syndrome in children. Int J Nephrol Renovasc Dis 2014;7:231-9. [PMID: 24966691 DOI: 10.2147/IJNRD.S41837] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
73 Mojiri A, Alavi P, Jahroudi N. Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease. Microcirculation 2018;:e12510. [PMID: 30365187 DOI: 10.1111/micc.12510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
74 Keir LS, Langman CB. Complement and the kidney in the setting of Shiga-toxin hemolytic uremic syndrome, organ transplantation, and C3 glomerulonephritis. Transfus Apher Sci 2016;54:203-11. [PMID: 27156109 DOI: 10.1016/j.transci.2016.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
75 Sciascia S, Cuadrado MJ, Khamashta M, Roccatello D. Renal involvement in antiphospholipid syndrome. Nat Rev Nephrol. 2014;10:279-289. [PMID: 24642799 DOI: 10.1038/nrneph.2014.38] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
76 Li XY, Mai YF, Huang J, Pai P. Gastrointestinal infection-related disseminated intravascular coagulation mimicking Shiga toxin-mediated hemolytic uremic syndrome - implications of classical clinical indexes in making the diagnosis: A case report and literature review. World J Clin Cases 2019; 7(13): 1660-1670 [PMID: 31367625 DOI: 10.12998/wjcc.v7.i13.1660] [Reference Citation Analysis]
77 Yamashita H, Kamei R, Kaneko H. Classifications of scleroderma renal crisis and reconsideration of its pathophysiology. Rheumatology (Oxford) 2019;58:2099-106. [PMID: 31566243 DOI: 10.1093/rheumatology/kez435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Harada H, Mitsuke A, Fukuzawa N, Kodama F, Hirose T, Tanaka T, Imamoto T, Tanaka H. Acute kidney injury caused by systemic Neisseria gonorrhoeae infection after successful kidney transplantation. Transpl Infect Dis 2018;20:e12987. [PMID: 30171774 DOI: 10.1111/tid.12987] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Li C, Yap DY, Chan G, Wen Y, Li H, Tang C, Li X, Li X, Chan TM. Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy. J Rheumatol 2019;46:1478-84. [DOI: 10.3899/jrheum.180773] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
80 Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184 [PMID: 25949931 DOI: 10.5527/wjn.v4.i2.169] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
81 Ahmed Ali EM, Abbakar NM, Abdel Raheem MB, Ellidir RA. Characteristics and outcome of hemolytic uremic syndrome in Sudanese children in a single Centre in Khartoum State. Sudan J Paediatr 2017;17:42-8. [PMID: 29545664 DOI: 10.24911/SJP.2017.2.5] [Reference Citation Analysis]
82 Martinez JT, Rogers LK, Kellogg C, Iazbik MC, Couto CG, Pressler BM, Hoepf TM, Radin MJ. Plasma Vasoprotective Eicosanoid Concentrations in Healthy Greyhounds and Non-Greyhound Dogs. J Vet Intern Med 2016;30:583-90. [PMID: 26806473 DOI: 10.1111/jvim.13833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
83 Lee SH, Park MS, Lee JG, Song JH, Chung KS, Jung JY, Kim EY, Kim YS, Kim SK, Chang J, Paik HC, Kim SY. Rare causes of hyperbilirubinemia after lung transplantation: our experience at a single center. J Thorac Dis 2017;9:5030-9. [PMID: 29312707 DOI: 10.21037/jtd.2017.11.118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
84 Yang F, Tian J, Peng L, Zhang L, Liu J, Tian X, Zhang W, Li M, Zhao Y, Zhang F, Zeng X, Wang L, Leng X. Thrombocytopenia Is an Independent Risk Factor for the Prognosis of Thrombotic Microangiopathy in Chinese Patients With Systemic Lupus Erythematosus. Front Med (Lausanne) 2021;8:772607. [PMID: 34820404 DOI: 10.3389/fmed.2021.772607] [Reference Citation Analysis]
85 Nzerue C, Oluwole K, Adejorin D, Paueksakon P, Fremont R, Akatue R, Faulkner M. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI). Clin Kidney J 2014;7:586-9. [PMID: 25503954 DOI: 10.1093/ckj/sfu116] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
86 Rathnayaka RMMKN, Ranathunga PEAN, Kularatne SAM. Kidney injury following envenoming by hump-nosed pit viper (Genus: Hypnale) in Sri Lanka: proven and probable cases. Trans R Soc Trop Med Hyg 2019;113:131-42. [PMID: 30544230 DOI: 10.1093/trstmh/try120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
87 Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 2017;30:347-62. [PMID: 27848226 DOI: 10.1007/s40620-016-0357-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
88 Vester U, Mache CJ. Pharmacological treatment of atypical hemolytic-uremic syndrome. Expert Opinion on Orphan Drugs 2014;2:123-35. [DOI: 10.1517/21678707.2014.872029] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Sana G, Dragon-Durey MA, Charbit M, Bouchireb K, Rousset-Rouvière C, Bérard E, Salomon R, Frémeaux-Bacchi V, Niaudet P, Boyer O. Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses. Pediatr Nephrol 2014;29:75-83. [PMID: 23868108 DOI: 10.1007/s00467-013-2558-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
90 Martin K, Roberts V, Chong G, Goodman D, Hill P, Ierino F. Eculizumab therapy in gemcitabine-induced thrombotic microangiopathy in a renal transplant recipient. Oxf Med Case Reports 2019;2019:omz048. [PMID: 31214360 DOI: 10.1093/omcr/omz048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
91 Tang H, Zhang L, Zhao W, Chen R, Xie M. A case of IgA nephropathy with deep venous thrombosis in the mesentery and lower extremities. Quant Imaging Med Surg 2018;8:1123-8. [PMID: 30701167 DOI: 10.21037/qims.2018.11.05] [Reference Citation Analysis]
92 Cao M, Ferreiro T, Leite BN, Pita F, Bolaños L, Valdés F, Alonso A, Vázquez E, Mosquera J, Trigás M, Rodríguez S. Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship. CEN Case Rep 2017;6:91-7. [PMID: 28509134 DOI: 10.1007/s13730-017-0251-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
93 Nicolay JP, Thorn V, Daniel C, Amann K, Siraskar B, Lang F, Hillgruber C, Goerge T, Hoffmann S, Gorzelanny C, Huck V, Mess C, Obser T, Schneppenheim R, Fleming I, Schneider MF, Schneider SW. Cellular stress induces erythrocyte assembly on intravascular von Willebrand factor strings and promotes microangiopathy. Sci Rep 2018;8:10945. [PMID: 30026593 DOI: 10.1038/s41598-018-28961-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
94 Shirai H, Yashima J, Tojimbara T, Honda K. Thrombotic microangiopathy caused by oral contraceptives in a kidney transplant recipient. Nephrology (Carlton) 2016;21 Suppl 1:41-3. [PMID: 26970708 DOI: 10.1111/nep.12769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
95 Ben-Amor AF, Trochanov A, Fischer TZ. Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a. Adv Ther 2015;32:445-54. [PMID: 25991578 DOI: 10.1007/s12325-015-0212-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
96 Perrone S, Passucci M, Ortu La Barbera E, Capriata M, Ferretti A, Mecozzi A, Giovangrossi P, Equitani F, Cimino G. Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura. J Clin Apher 2021;36:499-504. [PMID: 33459440 DOI: 10.1002/jca.21877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Yeturi S, Cronin M, Robin A, Lorna C, Rosenthal AK. Pauci-Immune Crescentic Glomerulonephritis in Connective Tissue Disease. Case Rep Rheumatol 2016;2016:9070487. [PMID: 27504208 DOI: 10.1155/2016/9070487] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Edens C, Rodrigues BC, Lacerda MI, Dos Santos FC, De Jesús GR, De Jesús NR, Levy RA, Leatherwood C, Mandel J, Bermas B. Challenging cases in rheumatic pregnancies. Rheumatology (Oxford) 2018;57:v18-25. [PMID: 30137591 DOI: 10.1093/rheumatology/key172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Carron PL, Cartier JC, Truche AS, Brunelle C, Cartier J, Malvezzi P, Ponard D. Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still's disease. Transfus Apher Sci 2013;49:533-4. [PMID: 23562215 DOI: 10.1016/j.transci.2013.02.040] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]